Valuation: Treace Medical Concepts, Inc.

Market Cap 288M 252M 233M 215M 405M 27.67B 412M 2.77B 1.09B 13.55B 1.08B 1.06B 46.65B P/E 2026 *
-4.93x
P/E 2027 * -5.31x
Enterprise Value 333M 291M 269M 249M 468M 31.99B 477M 3.21B 1.26B 15.67B 1.25B 1.22B 53.94B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.7x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day+1.58%
1 week+5.72%
Current month+13.69%
1 month+15.43%
3 months+102.91%
6 months+70.75%
Current year+84.69%
1 week 4.15
Extreme 4.15
4.74
1 month 3.76
Extreme 3.755
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.16
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 64 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
+1.58%+5.72%-21.30%-81.42% 288M
+0.23%-0.03%+34.17%+1.18% 12.44B
-0.10%+3.25%+9.81%+12.19% 5.85B
-4.68%-6.32%+51.75%+27.45% 5.96B
+4.26%+5.06% - - 4.22B
+4.41%+15.10%-27.14%+20.94% 4.25B
+2.12%+5.69%-20.77%-22.62% 3.96B
-1.72%-2.17%-3.23%+251.17% 1.89B
+2.09%-8.46%-5.30%-60.81% 1.8B
+1.66%+2.96%+55.09%-1.13% 1.54B
Average +1.01%+0.13%+8.12%+16.33% 4.22B
Weighted average by Cap. +0.56%+0.45%+17.28%+15.47%

Financials

2026 *2027 *
Net sales 206M 180M 167M 154M 290M 19.81B 295M 1.99B 780M 9.7B 775M 758M 33.41B 222M 194M 179M 166M 312M 21.31B 317M 2.14B 838M 10.43B 833M 815M 35.92B
Net income -58.31M -50.95M -47.1M -43.52M -81.95M -5.6B -83.44M -562M -220M -2.74B -219M -214M -9.44B -54.66M -47.77M -44.16M -40.8M -76.83M -5.25B -78.22M -527M -207M -2.57B -205M -201M -8.85B
Net Debt 45.05M 39.37M 36.4M 33.63M 63.32M 4.33B 64.47M 434M 170M 2.12B 169M 165M 7.3B 88.04M 76.94M 71.13M 65.71M 124M 8.46B 126M 848M 333M 4.14B 331M 323M 14.26B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-15 US$4.525 +1.91% 126,527
26-07-14 US$4.440 -3.06% 560,918
26-07-13 US$4.580 +6.02% 711,461
26-07-10 US$4.320 -7.30% 431,318
26-07-09 US$4.660 +8.88% 475,518
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.440USD
Average target price
4.000USD
Spread / Average Target
-9.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock